 | Axsome Therapeutics, Inc. | |||
| NGM : AXSM || Location: United States | ||||
$71.71+0.19 (+0.27%) |
0.27 M | 69.7 - 72.43 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 7.749 M |
| March 28, 2024 | 7.651 M |
| March 15, 2024 | 7.298 M |
| Feb. 29, 2024 | 7.470 M |
| Feb. 15, 2024 | 7.515 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.19 | -2.08 | -74.12% |
| 09/30/2023 | -1.23 | -1.32 | -7.52% |
| 06/30/2023 | -1.25 | -1.54 | -23.51% |
| 03/31/2023 | -1.06 | -0.26 | 75.39% |
| 12/31/2022 | -1.16 | -1.41 | -21.43% |
AXSM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 47.374M | Shares Float | 34.877M |
| Short Float | 7.749M | Market Cap | 3388.19M |
| Institution ownership | 83.57% | Insider ownership | 17.122% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -5.27 | Forward EPS | 1.13 |